The National Agency for Food and Drug Administration and Control (NAFDAC) has warned Nigerians against the use of a drug marketed on the internet under the brand name Tafrodol by Deep Pharmaceutical, Mumbai, Maharashtra, India with active ingredients for Tafrodol declared by the manufacturer are Tapentadol Hcl 100mg and Carisoprodol 125mg.
Tapentadol is an opioid analgesic and Carisoprodol is a muscle relaxant with Central Nervous System(CNS) depressing properties. Tafrodol contains two groups of drugs that should not be routinely used together. Using them together can result in serious side effects including profound sedation, respiratory depression, coma, and/or death.
The agency reportedly said that NAFDAC has not authorized Tafrodol for sale in Nigeria because it exposes consumers to the risk of purchasing substandard/ falsified medicines or medicines that are not safe for use. The use of such medicines may worsen the disease condition or cause other harm.
NAFDAC reportedly advised Nigerians to consult their healthcare providers if they have moderate to severe pain that requires analgesics that are not sold over the counter.
NAFDAC reportedly implored the public to purchase drugs and other medical products only from genuine and trusted pharmacies while advising importers, distributors, retailers, healthcare providers, and consumers to exercise caution and vigilance to avoid the importation, distribution, sale, and use of Tafrodol
The agency encouraged the consumers to report adverse events related to the use of medicines to the nearest NAFDAC office.